Bottom line
ERX vs CURE: the short answer
ERX (Direxion Daily Energy Bull 2X ETF) and CURE (Direxion Daily Healthcare Bull 3X ETF) are both etfs.
But CURE is far broader, holding 67 positions to 29 for ERX, so beyond the top names it adds exposure ERX doesn't have.
ERX is cheaper at 0.91% vs 0.94% — a difference of $3.00 a year per $10,000 invested.
Over five years, ERX returned +34.8% a year vs +8.6% for CURE.
Updated Nov 19, 2026
ERX vs CURE side by side
| ERX | CURE | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.91% | 0.94% |
| Annual cost per $10k | $91 | $94 |
| 10-yr cost on $10k (prospectus) | $1,120 | $1,155 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +3.1% | +22.9% |
| 5-yr return (annualized) | +34.8% | +8.6% |
| 10-yr return (annualized) | −11.6% | +13.6% |
| Best quarter | +88.3% | +46.9% |
| Worst quarter | −94.5% | −45.8% |
| Net assets (fund) | $233.5M | $171.7M |
| Number of holdings | 29 | 67 |
| Portfolio turnover | 8% | 1% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | ERX | CURE | Difference |
|---|---|---|---|
| 2025 | +3.1% | +22.9% | −19.8% |
| 2024 | +0.8% | −8.5% | +9.4% |
| 2023 | −12.3% | −9.8% | −2.5% |
| 2022 | +131.0% | −20.4% | +151.4% |
| 2021 | +111.4% | +87.4% | +24.0% |
| 2020 | −91.6% | +5.1% | −96.7% |
| 2019 | +17.4% | +55.9% | −38.4% |
| 2018 | −55.8% | +2.9% | −58.8% |
| 2017 | −11.7% | +69.3% | −81.0% |
| 2016 | +69.8% | −17.4% | +87.2% |
Source: Fund prospectus bar charts
Holdings overlap
6 of ERX's top 25 holdings also appear in CURE's top 25.
| Holding | ERX | CURE |
|---|---|---|
| Dreyfus | 21.22% | 18.79% |
| N/a | 7.77% | 1.12% |
| Goldman Financial | 6.74% | 7.51% |
| N/a | 4.15% | 1.12% |
| N/a | 1.86% | 1.12% |
| N/a | 1.01% | 1.12% |
Source: SEC Form N-PORT
ERX top 10
- Dreyfus — 21.22%
- Exxonmobil Holdings Corp — 14.59%
- Chevron Corp — 10.81%
- N/a — 7.77%
- Goldman Financial — 6.74%
- Conocophillips — 4.31%
- N/a — 4.15%
- Marathon Petroleum Corp — 3.49%
- Phillips 66 — 3.48%
- Valero Energy Corp — 3.36%
CURE top 10
- Dreyfus — 18.79%
- Eli Lilly & Company — 10.41%
- N/a — 8.28%
- Goldman Sachs Liq Es Fd A — 8.19%
- Goldman Financial — 7.51%
- Johnson & Johnson — 7.07%
- Abbvie Inc — 5.08%
- Unitedhealth Group Inc — 4.31%
- Merck & Company Inc — 3.68%
- N/a — 3.34%
FAQ
What is the difference between ERX and CURE?
Which is cheaper, ERX or CURE?
Should I own both ERX and CURE?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.